1. Home
  2. SCM vs TECX Comparison

SCM vs TECX Comparison

Compare SCM & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCM
  • TECX
  • Stock Information
  • Founded
  • SCM 2012
  • TECX 2019
  • Country
  • SCM United States
  • TECX United States
  • Employees
  • SCM N/A
  • TECX N/A
  • Industry
  • SCM Finance/Investors Services
  • TECX
  • Sector
  • SCM Finance
  • TECX
  • Exchange
  • SCM Nasdaq
  • TECX Nasdaq
  • Market Cap
  • SCM 392.4M
  • TECX 334.4M
  • IPO Year
  • SCM 2012
  • TECX 2018
  • Fundamental
  • Price
  • SCM $13.73
  • TECX $19.81
  • Analyst Decision
  • SCM Hold
  • TECX Buy
  • Analyst Count
  • SCM 1
  • TECX 7
  • Target Price
  • SCM $13.00
  • TECX $78.67
  • AVG Volume (30 Days)
  • SCM 113.5K
  • TECX 156.7K
  • Earning Date
  • SCM 08-06-2025
  • TECX 08-13-2025
  • Dividend Yield
  • SCM 11.63%
  • TECX N/A
  • EPS Growth
  • SCM 26.74
  • TECX N/A
  • EPS
  • SCM 1.42
  • TECX N/A
  • Revenue
  • SCM $103,691,042.00
  • TECX N/A
  • Revenue This Year
  • SCM $1.85
  • TECX N/A
  • Revenue Next Year
  • SCM $2.30
  • TECX N/A
  • P/E Ratio
  • SCM $9.66
  • TECX N/A
  • Revenue Growth
  • SCM N/A
  • TECX N/A
  • 52 Week Low
  • SCM $11.19
  • TECX $13.70
  • 52 Week High
  • SCM $15.56
  • TECX $61.07
  • Technical
  • Relative Strength Index (RSI)
  • SCM 58.77
  • TECX 40.56
  • Support Level
  • SCM $13.49
  • TECX $22.13
  • Resistance Level
  • SCM $13.80
  • TECX $25.75
  • Average True Range (ATR)
  • SCM 0.23
  • TECX 1.44
  • MACD
  • SCM 0.03
  • TECX -0.48
  • Stochastic Oscillator
  • SCM 84.62
  • TECX 10.68

About SCM Stellus Capital Investment Corporation

Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through a first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. The business activity of the firm is functioned through the United States and it generates revenue in the form of interest income on debt investments and capital gains and distributions.

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: